ORMP Oramed Pharmaceuticals4.97+0.88 (+21.5%)
ORMP Oramed Pharmaceuticals3.53+0.14 (+4.1%)
ORMP Oramed Pharmaceuticals2.35-0.19 (-7.5%)
ORMP Oramed Pharmaceuticals2.52-8.27 (-76.7%)
Premarket Decliner
ORMP Oramed Pharmaceuticals10.79+0.59+5.8%
Premarket:3.36-7.43 (-68.9%)
Oramed Announces Top-line Results from Phase 3 Trial of ORMD-0801 for the Treatment of Type 2 Diabetes
PRNewswireWed, 11-Jan 8:00 PM